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Abstract: 
Dispensing iron tablets to pregnant women at antenatal clinics is a common practice in Sudan.  Iron 
overload and, consequently, oxidative stress is a possible risk.  
Objective: In this study, we examined the iron status in pregnant women in correlation to pregnancy 
outcome.  
 Subjects and methods: The study was conducted in Khartoum state, Sudan in the period December 
2007 – February 2009. Venous blood samples were obtained from 123 women at delivery. 
Undesirable pregnancy outcomes as preeclampsia, low birth weight, caesarean sections and preterm 
delivery, if any, were recorded. Serum iron and hematological parameters were determined.  
Results: Mothers were grouped, according to their serum iron levels, as low serum iron (LSI: < 50 
µg/dl, n=14), normal serum iron (NSI: 50 - 170 µg/dl, n=98) and iron overload (IOL: >170 µg/dl, 
n=11) groups. The incidence of preeclampsia was highest among the IOL group (72.7%), followed 
by the LSI group (35.7%) and lowest among the NSI (19.4%) group, p=. The mean babies’ birth 
weights were comparable among the IOL and the LSI groups but both were significantly lower than 
that among the NSI group.  
Conclusion: Iron supplementation to pregnant women must be rationalized so that women will 
benefit without developing undesirable effects. 
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ypertensive disorders complicating 
pregnancy are common and form one 
of the deadly traits, along with 
haemorrhage and infection that results in 
much of the maternal morbidity and mortality 
related to pregnancy. Pregnancy induced 
hypertension is a potential precursor of 
preeclampsia or eclampsia, which require the 
presence of proteinuria for diagnosis1. The 
combination of proteinuria and hypertension 
during pregnancy markedly increases the risk 
of prenatal mortality and morbidity2. The 
maternal preeclampsia occurs mostly in 
multiparous patients with known risk factors 
of preeclampsia such as insulin resistance, 
diabetes mellitus, obesity and chronic 
hypertension3.  
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Other risk factors associated with 
preeclampsia include African American 
ethnicity4, 5. It has been proposed that 
maternal endothelial cell dysfunction is the 
key event resulting in the diverse clinical 
manifestations of preeclampsia. Current 
concepts of the genesis of preeclampsia 
include endothelial dysfunction and oxidative 
stress6-9. The factors that lead to endothelial 
cell dysfunction have not been determined 
with certainty, but the evidence points to poor 
placentation10-12. The effect of poor 
placentation is to leave the spiral arteries 
smaller than normal for the second half of 
pregnancy. The obstructive lesion of the spiral 
arteries, called acute atherosis, leads to 
placental ischaemia and the malperfused 
placenta is a likely site for the production of 
reactive oxygen species such as superoxide 
and hydrogen peroxide13,14. But neither of 
these is reactive enough to initiate cellular 
damage directly. One hypothesis receiving 
increased attention is that placental and 
maternal free radical reactions promote a 
cycle of events that compromise the defensive 
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functioning of the vascular endothelium in 
preeclampsia. Since the time that data 
relevant to this hypothesis were initially 
reviewed15; a significant body of new 
information has been generated. It has been 
suggested that reduced antioxidants and 
increased oxidative stress leading to impaired 
essential polyunsaturated fatty acid levels 
may be a key factor in the development of 
pre-eclampsia16. Antioxidant vitamins directly 
scavenge reactive oxygen species and up 
regulate the activities of antioxidant enzymes. 
Among them, vitamin E and carotenoids have 
attracted most attention as antioxidants 
important in human diseases including 
preeclampsia17,18. Thus, variations in these 
antioxidants in patients with preeclampsia 
may be of considerable clinical importance. In 
the presence of catalytic amounts of transition 
metal ions, particularly iron and copper, the 
reactive oxygen species can generate the 
highly reactive hydroxyl radical by Fenton 
chemistry. This radical can initiate the process 
of lipid peroxidation, which if uncontrolled, 
may result in endothelial cell damage18,19. 
Some studies demonstrate that serum iron20-23 
levels are elevated in preeclampsia. An iron 
supplement during pregnancy is a common 
practice in Sudan because of the high 
prevalence of anaemia among pregnant 
women24. However, the possible burden and 
impact of iron status on pregnancy outcome 
has not been studied. This is a cross – 
sectional study aiming to present preliminary 
data on the effect of serum iron level on the 
development of preeclampsia among 
Sudanese pregnant women. 
Methods: 
The study was ethically approved by the 
committee of the college of applied and 
industrial sciences, university of Juba, Sudan. 
It was carried out in Khartoum state- Sudan, in 
the period December 2007 till February 2009. 
Participants were recruited from Rabat, 
Bashaer, Omudurman, Alsaudi and Khartoum 
Teaching Hospitals. One hundred and twenty 
three women were included, mothers of >35 
years age and those with glucosuria were 
excluded. A questionnaire form including 
personal data was completed for each 
participant. A five ml venous blood sample 
was obtained at delivery after taking the 
consent of participant.  Samples were divided 
into 2 aliquots, 2.5 ml in plain tubes to obtain 
serum for iron determination and 2.5 ml in 
EDTA tubes for haematological 
determinations.  
Haematological parameters including 
haemoglobin (Hb), mean red cell volume 
(MCV) and packed cell volume (PCV) were 
determined using automated methods sysmex 
haemoglobin system, (Sysmex NE 8000). Iron 
ferrozine kits (REF 1135005, Linear 
Chemicals S.L., Spain) was used for 
determination of serum iron.  
 
Results: 
Mothers were grouped, according to their 
serum iron levels, as low serum iron (LSI: < 50 
µg/dl), normal serum iron (NSI: 50 - 170 
µg/dl) and iron overload (IOL: >170 µg/dl) 
groups. Age range was 15 – 35 years.  All 
subjects were taking routine iron supplements 
of 150 mg/day ferrous sulphate sustained 
release capsules containing 500 micrograms 
folic acid. There were no significant 
differences between the three groups as far as 
age, parity, DBP, MCV (table 1) and 
frequencies of caesarean sections (C/S) and 
preterm deliveries (table 2) were considered. 
However, mean Hb and PCV were comparable 
among the NSI and the IOL and significantly 
higher than that of the LSI group (table 1). The 
incidence of preeclampsia was highest among 
the IOL group (72.7%), followed by the LSI 
group (35.7%) and lowest among the NSI 
(19.4%) group, p = 0.00. The mean babies’ 
birth weights were comparable among the IOL 
and the LSI groups but both were significantly 
lower than that among the NSI group, p = 
0.041 (tables 1 and 2). 
 
Discussion and conclusion:  
This cross – sectional study showed an 
evident association between iron status and 
pregnancy outcomes, namely development of 
preeclampsia and low birth weight among the 
study subjects. Both LSI and IOL groups 
showed higher frequencies of preeclampsia 
and LBW compared to the NSI group.  
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Table 1: Age, parity, diastolic blood pressure and haematological parameters among women with 




LSI (< 50 µg/dl) 
(14) 
NSI (50 - 170 µg/dl) 
(98) 
IOL (>170 µg/dl) 
(11) 
P - values 
Age     
mean±SE 23.8±1.05 27.8±0.55 27.2±1.50 0.015 
median 25.5 30 29  
Parity     
mean± SE 2.2±0.49 2.75±1.78 4.0±3.0 0.519 
median 1.5 2.5 3  
DBP     
mean± SE 85.4±5.7 80.8±1.29 88.0±5.3 0.369 
median 80 80 90  
Hb     
mean± SE 8.9±0.21 11.2±0.18 11.0±0.68 0.0000 
median 9.3 11.8 11.6  
PCV     
mean± SE 27.6±0.74 32.61±0.59 33.95±2.18 0.00017 
median 28.5 34.0 33.0  
MCV     
mean± SE 77.6±2.14 82.50±0.76 85.0±2.84 0.093 
median 80.2 84.2 85.4  
Serum Iron     
mean± SE 39.2±1.96 100.5±3.37 193.8±7.71 0.000 
median 40 94.5 190  
 
 
Table 2: Frequency of preeclampsia, C/S and preterm delivery among women with different serum  




LSI (< 50 µg/dl) 
(14) 
NSI (50 - 170 µg/dl) 
(98) 
IOL (>170 µg/dl) 
(11) 
*P - values 
Preeclampsia 5 (35.7%) 19 (19.4%) 8 (72.7%) 0.00 
**LBW babies 2/12 (16.7%) 2/85 (2.4%) 0/8 (0.0%) 0.041 
C/S 7 (50%) 32 (32.6%) 4 (36.4%) 0.352 
Preterm delivery 2 (14.3%) 3 (3.1%) 1 (9.1%) 0.095 
 
*P- values were obtained by Fisher exact test. 
**Some data on birth weight are not available. 
 
Our results are in agreement with a previous 
observation that iron excess and deficiency are 
known conditions under which free radical 
damage has been observed25. This damage may 
be accompanied by high incidence of bad 
pregnancy outcomes such as preeclampsia16. 
On the other hand, according to our results,  
 
women with NSI or IOL were at a better status 
as far as Hb concentration, MCV and rate of 
caesarean section are concerned. Iron 
supplementation for pregnant women is a 
routine practice in Sudan.  Benefits and risks 
of iron supplementation during pregnancy have 
been reviewed26. Contradicting results were 
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obtained concerning the benefits of iron 
supplementation on mother and foetus. Some 
studies have shown that iron supplementation 
during pregnancy improves maternal iron 
status as reflected by Hb level and MCV and 
reduces rate of caesarean section and improves 
foetal growth as shown by increased mean 
birth weight  and higher mean gestational age 
at delivery27-31. However, iron 
supplementation, depending on the dose, has 
been shown to have a variety of outcomes. 
Doses of 36 – 100 mg/ day may exacerbate 
oxidative stress32,33. Sixty mg/ day increase Hb 
above 130 g/L leading to negative effects34,35. 
Supplements of more than 30 mg/day are also 
accompanied by gastrointestinal symptoms27. 
This study alarms antenatal care providers in 
Sudan to rationalize iron supplementation so 
that pregnant women would benefit without 
developing undesirable effects.  
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